News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
574,967 Results
Type
Article (42555)
Company Profile (265)
Press Release (532147)
Section
Business (161681)
Career Advice (945)
Deals (28747)
Drug Delivery (87)
Drug Development (71297)
Employer Resources (94)
FDA (15200)
Job Trends (12978)
News (282988)
Policy (28623)
Tag
Academia (2504)
Alliances (41990)
Alzheimer's disease (1143)
Approvals (15150)
Artificial intelligence (145)
Bankruptcy (217)
Best Places to Work (10792)
Biotechnology (199)
Breast cancer (187)
Cancer (1317)
Cardiovascular disease (102)
Career advice (825)
CAR-T (90)
Cell therapy (267)
Clinical research (57027)
Collaboration (427)
Compensation (222)
COVID-19 (2431)
C-suite (101)
Data (1326)
Diabetes (149)
Diagnostics (5303)
Drug pricing (93)
Earnings (60190)
Events (89668)
Executive appointments (351)
FDA (15821)
Funding (369)
Gene therapy (181)
GLP-1 (547)
Government (4271)
Healthcare (18191)
Infectious disease (2517)
Inflammatory bowel disease (117)
Interviews (116)
IPO (13453)
Job creations (2648)
Job search strategy (762)
Layoffs (283)
Legal (5943)
Lung cancer (190)
Manufacturing (162)
Medical device (13521)
Medtech (13525)
Mergers & acquisitions (15499)
Metabolic disorders (400)
Neuroscience (1417)
NextGen Class of 2024 (5852)
Non-profit (4059)
Northern California (1575)
Obesity (235)
Opinion (137)
Patents (92)
People (48473)
Phase I (17586)
Phase II (24922)
Phase III (19223)
Pipeline (465)
Postmarket research (2313)
Preclinical (7235)
Radiopharmaceuticals (240)
Rare diseases (236)
Real estate (4459)
Regulatory (19762)
Research institute (2280)
Resumes & cover letters (115)
Southern California (1295)
Startups (3138)
United States (13715)
Vaccines (574)
Weight loss (164)
Date
Today (39)
Last 7 days (593)
Last 30 days (2230)
Last 365 days (32984)
2024 (32226)
2023 (37688)
2022 (47904)
2021 (51703)
2020 (49643)
2019 (42669)
2018 (32128)
2017 (28661)
2016 (27365)
2015 (31803)
2014 (23824)
2013 (19855)
2012 (21185)
2011 (21374)
2010 (19457)
Location
Africa (611)
Arizona (128)
Asia (39894)
Australia (6387)
California (3445)
Canada (1210)
China (273)
Colorado (166)
Connecticut (171)
Europe (77943)
Florida (468)
Georgia (120)
Illinois (349)
Indiana (216)
Maryland (615)
Massachusetts (2766)
Michigan (112)
Minnesota (255)
New Jersey (998)
New York (949)
North Carolina (726)
Northern California (1575)
Ohio (119)
Pennsylvania (811)
South America (839)
Southern California (1295)
Texas (464)
Utah (98)
Washington State (369)
574,967 Results for "medi immune ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical
December 2, 2024
·
6 min read
Press Releases
WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024
November 28, 2024
·
4 min read
Biotech Beach
Evofem Negotiates Improved Rebate for Hormone-Free “In the Moment” Contraceptive PHEXXI with Medi-Cal
Commercial-stage women’s health innovator Evofem Biosciences, Inc. announced that it has successfully renegotiated the rebate for Phexxi®, its hormone-free, woman-controlled contraceptive, with Medi-Cal, the California state Medicaid program.
March 20, 2024
·
3 min read
Press Releases
Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders
December 9, 2024
·
3 min read
Press Releases
Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region
December 2, 2024
·
6 min read
Press Releases
Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch
December 12, 2024
·
5 min read
Press Releases
Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
November 18, 2024
·
7 min read
Press Releases
Tenpoint Therapeutics Ltd. and Visus Therapeutics, Inc. Join Forces, Building the Next Era of Best- and First-in-Class Ophthalmic Medicines
December 12, 2024
·
4 min read
Press Releases
Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.
December 3, 2024
·
4 min read
Meihua International Medical Technologies Co., Ltd. Announces Share Repurchase Program of Up to $3 million
Meihua International Medical Technologies Co., Ltd., a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced that its board of directors has approved and authorized a share repurchase program of up to $3 million of the Company’s outstanding ordinary shares.
July 1, 2024
·
5 min read
1 of 57,497
Next